![](https://scdn.x-mol.com/css/images/icon-new-link.png)
样式: 排序: IF: - GO 导出 标记为已读
-
No Time for Cancel Culture: The Importance of Banff Pathology Criteria and Clinical Outcomes J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-06-10 Michael Mengel, Roslyn B. Mannon
An abstract is unavailable.
-
Authors' Reply: Dialysate Sodium and Mortality: One Size Does Not Fit All J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-06-06 Jule Pinter, Brendan Smyth, Meg Jardine
An abstract is unavailable.
-
Authors' Reply: Dialysate Sodium and Mortality: 140 mmol/L at Hemodialysis Initiation by Default? J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-06-06 Jule Pinter, Meg Jardine, Bernard Canaud, Bernd Genser
An abstract is unavailable.
-
Dialysate Sodium and Mortality: 140 mmol/L at Hemodialysis Initiation by Default? J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-06-06 Manfred Hecking, Angelo Karaboyas, Simon Krenn, Sebastian Mussnig, Joachim Beige, Charles Chazot, Roberto Pecoits-Filho, Hugh Rayner, Friedrich K. Port
An abstract is unavailable.
-
Long Noncoding RNAs in Single Cells J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-06-03 Qiongzi Qiu, Mingyu Liang
An abstract is unavailable.
-
Blood Proteomics for Biomarkers of Kidney Pathology J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-05-31 Andrew Beenken, Krzysztof Kiryluk
An abstract is unavailable.
-
From the Beginning to the End: Effects of Proteinuria along the Renal Tubule J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-05-30 Louisa M.S. Gerhardt
An abstract is unavailable.
-
Dialysate Sodium and Mortality: One Size Does Not Fit All J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-05-29 Guillaume Fernandes, Jean-Michel Pochet, Laura Labriola
An abstract is unavailable.
-
Proton Pump Inhibitors and CKD: The Evidence Builds J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-05-28 Morgan E. Grams, F. Perry Wilson
An abstract is unavailable.
-
Advancing Care for AA Amyloidosis with Biomarker-Based Staging J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-05-15 Helen J. Lachmann
An abstract is unavailable.
-
Mechanisms for Mitoprotection and Amelioration of Acute Kidney Injury Risk J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-05-15 Guanshi Zhang, Kumar Sharma
An abstract is unavailable.
-
The Gut Microbial Metabolite Trimethylamine N-oxide, Incident CKD, and Kidney Function Decline J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-05-09 Meng Wang, W.H. Wilson Tang, Xinmin S. Li, Marcia C. de Oliveira Otto, Yujin Lee, Rozenn N. Lemaitre, Amanda Fretts, Ina Nemet, Nona Sotoodehnia, Colleen M. Sitlani, Matthew Budoff, Joseph A. DiDonato, Zeneng Wang, Nisha Bansal, Michael G. Shlipak, Bruce M. Psaty, David S. Siscovick, Mark J. Sarnak, Dariush Mozaffarian, Stanley L. Hazen
ay prevent CKD development and progression. Background Trimethylamine N-oxide (TMAO) is a gut microbiota–derived metabolite of dietary phosphatidylcholine and carnitine. Experimentally, TMAO causes kidney injury and tubulointerstitial fibrosis. Little is known about prospective associations between TMAO and kidney outcomes, especially incident CKD. We hypothesized that higher plasma TMAO levels would
-
Engaging Patients in Decision Making about Treatment of Kidney Failure: The Art and Science of Communication J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-05-07 Jennifer deGraauw, Susan P.Y. Wong
An abstract is unavailable.
-
JASN: The Next Chapter J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-05-02 Rajnish Mehrotra
An abstract is unavailable.
-
Endothelial–Mesenchymal Transition Switch and Diabetic Kidney Disease J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-05-02 Tomohito Doke, Petter Bjornstad
An abstract is unavailable.
-
Patient-Reported Outcomes as End Points in Nephrology Trials: Designing the Right Trial for the Right Question J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-04-30 Linda-Marie Ustaris Lavenburg, Manisha Jhamb
An abstract is unavailable.
-
Neighborhood Racial and Ethnic Segregation and the Risk of Dementia in Older Adults Living with Kidney Failure J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-04-26 Yiting Li, Gayathri Menon, Jane J. Long, Yusi Chen, Garyn T. Metoyer, Wenbo Wu, Deidra C. Crews, Tanjala S. Purnell, Roland J. Jr. Thorpe, Carl V. Hill, Sarah L. Szanton, Dorry L. Segev, Mara A. McAdams-DeMarco
ng in minority-predominant high-segregation neighborhoods had a 2.19-fold higher risk of dementia diagnosis compared with White individuals in White-predominant neighborhoods. Background Dementia disproportionately affects older minoritized adults with kidney failure. To better understand the mechanism of this disparity, we studied the role of racial and ethnic segregation (segregation hereafter),
-
Plasma Proteins Associated with Chronic Histopathologic Lesions on Kidney Biopsy J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-04-24 Taesoo Kim, Aditya L. Surapaneni, Insa M. Schmidt, Michael T. Eadon, Sahir Kalim, Anand Srivastava, Ragnar Palsson, Isaac E. Stillman, Jeffrey B. Hodgin, Rajasree Menon, Edgar A. Otto, Josef Coresh, Morgan E. Grams, Sushrut S. Waikar, Eugene P. Rhee, for the Kidney Precision Medicine Project
r epithelial cells, released by the kidney into circulation, and inversely associated with interstitial fibrosis and tubular atrophy severity. Background The severity of chronic histopathologic lesions on kidney biopsy is independently associated with higher risk of progressive CKD. Because kidney biopsies are invasive, identification of blood markers that report on underlying kidney histopathology
-
Grainyhead-like 2 Deficiency and Kidney Cyst Growth in a Mouse Model J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-04-24 Zeliha Yesim Yurtdas, Ergin Kilic, Peter Boor, Emanuel Wyler, Markus Landthaler, Klaus Jung, Kai M. Schmidt-Ott
ription factor grainyhead-like 2 (GRHL2) plays a crucial role in maintaining the epithelial barrier properties of the kidney collecting duct and is important to osmoregulation. We noticed a reduction in GRHL2 expression in cysts derived from the collecting ducts in kidneys affected by autosomal dominant polycystic kidney disease (ADPKD). However, the specific role of GRHL2 in cystic kidney disease
-
Acute Kidney Injury Receiving Dialysis and Dialysis Care after Hospital Discharge J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-04-23 Seda Babroudi, Daniel E. Weiner, Javier A. Neyra, David A. Drew
ialysis. Data to inform dialysis management strategies that promote kidney function recovery and processes of care among patients with AKI-D receiving outpatient dialysis are lacking. In this article, we detail current trends in the incidence, risk factors, clinical outcomes, proposed management, and health policy landscape for patients with AKI-D receiving outpatient dialysis and identify areas for
-
Spatiotemporal Landscape of Kidney Tubular Responses to Glomerular Proteinuria J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-04-23 Anna Faivre, Milica Bugarski, Anna Rinaldi, Imene B. Sakhi, Thomas Verissimo, David Legouis, Joseph M. Rutkowski, Sara Correia, Monika Kaminska, Delal Dalga, Daniele Malpetti, Pietro E. Cippa, Sophie de Seigneux, Andrew M. Hall
Large increases in glomerular protein filtration induce major changes in body homeostasis and are associated with a higher risk of kidney functional decline and cardiovascular disease. We investigated how elevated protein exposure modifies the landscape of tubular function along the entire nephron, to understand the cellular changes that mediate these important clinical phenomena. Methods We conducted
-
Association of Integrated Proteomic and Metabolomic Modules with Risk of Kidney Disease Progression J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-04-19 Pascal Schlosser, Aditya L. Surapaneni, Oleg Borisov, Insa M. Schmidt, Linda Zhou, Amanda Anderson, Rajat Deo, Ruth Dubin, Peter Ganz, Jiang He, Paul L. Kimmel, Hongzhe Li, Robert G. Nelson, Anna C. Porter, Mahboob Rahman, Hernan Rincon-Choles, Vallabh Shah, Mark L. Unruh, Ramachandran S. Vasan, Zihe Zheng, Harold I. Feldman, Sushrut S. Waikar, Anna Köttgen, Eugene P. Rhee, Josef Coresh, Morgan E.
Proteins and metabolites play crucial roles in various biological functions and are frequently interconnected through enzymatic or transport processes. Methods We present an integrated analysis of 4091 proteins and 630 metabolites in the Chronic Renal Insufficiency Cohort study (N=1708; average follow-up for kidney failure, 9.5 years, with 537 events). Proteins and metabolites were integrated using
-
The Clinical Relevance of the Infiltrating Immune Cell Composition in Kidney Transplant Rejection J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-04-19 Thibaut Vaulet, Jasper Callemeyn, Baptiste Lamarthée, Asier Antoranz, Tim Debyser, Priyanka Koshy, Dany Anglicheau, Jill Colpaert, Wilfried Gwinner, Philip F. Halloran, Dirk Kuypers, Claire Tinel, Amaryllis Van Craenenbroeck, Elisabet Van Loon, Pierre Marquet, Francesca Bosisio, Maarten Naesens
CD8temra cells showed strong and consistent association with graft failure, regardless of the Banff rejection phenotypes. Background The link between the histology of kidney transplant rejection, especially antibody-mediated rejection, T-cell–mediated rejection, and mixed rejection, and the types of infiltrating immune cells is currently not well charted. Cost and technical complexity of single-cell
-
Set7 Methyltransferase and Phenotypic Switch in Diabetic Glomerular Endothelial Cells J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-04-17 Scott Maxwell, Jun Okabe, Harikrishnan Kaipananickal, Hanah Rodriguez, Ishant Khurana, Keith Al-Hasani, Bryna S.M. Chow, Eleni Pitsillou, Tom C. Karagiannis, Karin Jandeleit-Dahm, Ronald C.W. Ma, Yu Huang, Juliana C.N. Chan, Mark E. Cooper, Assam El-Osta
ding protein 5.Set7 regulates the phenotypic EDMT switch, and inhibiting the methyltransferase attenuates glomerular injury in diabetic kidney disease. Background Hyperglycemia influences the development of glomerular endothelial cell damage, and nowhere is this more evident than in the progression of diabetic kidney disease (DKD). While the Set7 lysine methyltransferase is a known hyperglycemic sensor
-
Cell Type– and Age-Specific Expression of lncRNAs across Kidney Cell Types J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-04-15 Gyeong Dae Kim, So-I Shin, Su Woong Jung, Hyunsu An, Sin Young Choi, Minho Eun, Chang-Duk Jun, Sangho Lee, Jihwan Park
(lncRNAs) regulate cell differentiation and homeostasis, influencing kidney aging and disease. Despite their versatility, the function of lncRNA remains poorly understood because of the lack of a reference map of lncRNA transcriptome in various cell types. Methods In this study, we used a targeted single-cell RNA sequencing method to enrich and characterize lncRNAs in individual cells. We applied this
-
In Memoriam of William Lloyd Henrich, MD, MACP: What It Means to Be a Humble Servant Leader J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-04-11 Kumar Sharma, Jochen Reiser, Orson W. Moe, W. Brian Reeves
An abstract is unavailable.
-
Bridging Racial Disparities in Access to Kidney Transplantation in the United States: Glass Part-Empty or Part-Full? J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-04-11 Rachel E. Patzer
An abstract is unavailable.
-
The Effects of Pantoprazole on Kidney Outcomes: Post Hoc: Observational Analysis from the COMPASS Trial J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-04-11 Lonnie Pyne, Andrew Smyth, Amber O. Molnar, Paul Moayyedi, Eva Muehlhofer, Salim Yusuf, John Eikelboom, Jacqueline Bosch, Michael Walsh
outcomes. Background Observational studies have found an association between proton pump inhibitor use and worsening kidney function. It is unclear whether these associations are causal. We conducted post hoc analyses to determine the effect of pantoprazole on kidney function using data from the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial, a 17,598-participant
-
The Mechanism of Kidney Disease due to APOL1 Risk Variants: Involvement of Two Distinct Processes J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-04-10 Etienne Pays
An abstract is unavailable.
-
In Search of the Mechanism of APOL1 Kidney Disease J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-04-10 David J. Friedman, Martin R. Pollak
An abstract is unavailable.
-
Requiem for Urate Lowering in CKD? J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-04-10 David B. Mount
An abstract is unavailable.
-
Immunosuppression Withdrawal in Patients with Lupus Nephritis: When, How, and for Whom Will It Be Safe? J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-04-09 Eleni Frangou, Hans-Joachim Anders, Ingeborg M. Bajema, Y.K. Onno Teng, Ana Malvar, Brad H. Rovin, Andreas Kronbichler
An abstract is unavailable.
-
Equity in Preemptive Kidney Transplantation: The Case for Caution J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-04-08 Robert W. Steiner
An abstract is unavailable.
-
Consent for High–Kidney Donor Profile Index Kidneys: The Responsibility of Transplant Centers to Get it Right J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-04-08 Peter Stock, Charles Gerard Rickert
An abstract is unavailable.
-
Kidney Endothelial Cell Biology in Health and Disease J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-04-08 Sargis Sedrakyan
An abstract is unavailable.
-
Renal Intercalated Cell Differentiation and Acid–Base Regulation J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-04-08 Carsten A. Wagner
An abstract is unavailable.
-
-
A Requiem for Fistula First J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-04-01 Michael Allon, Timmy Lee
An abstract is unavailable.
-
Rab35 Is Required for Embryonic Development and Kidney and Ureter Homeostasis through Regulation of Epithelial Cell Junctions J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-03-26 Kelsey R. Clearman, Napassawon Timpratoom, Dharti Patel, Addison B. Rains, Courtney J. Haycraft, Mandy J. Croyle, Jeremy F. Reiter, Bradley K. Yoder
g proteins. Studies in cell lines have indicated that Rab35 participates in cell adhesion, polarity, cytokinesis, and primary cilia length and composition. In addition, sea urchin Rab35 regulates actin organization and is required for gastrulation. In mice, loss of Rab35 in the central nervous system disrupts hippocampal development and neuronal organization. Outside of the central nervous system,
-
Genome-Wide CRISPR Screen Identifies Phospholipid Scramblase 3 as the Biological Target of Mitoprotective Drug SS-31 J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-03-26 Josie A. Silvaroli, Bijay Bisunke, Ji Young Kim, Amanda Stayton, Laura A. Jayne, Shirely A. Martinez, Christopher Nguyen, Prisha S. Patel, Thitinee Vanichapol, Vivek Verma, Juheb Akhter, Subhashini Bolisetty, Sethu M. Madhavan, Cem Kuscu, Christopher C. Coss, Diana Zepeda-Orozco, Samir V. Parikh, Anjali A. Satoskar, Alan J. Davidson, James D. Eason, Hazel H. Szeto, Navjot S. Pabla, Amandeep Bajwa
mon diseases. However, the precise pharmacological basis of its mitoprotective effects remains unknown. Methods To uncover the biological targets of SS-31, we performed a genome-scale clustered regularly interspaced short palindromic repeats screen in human kidney-2, a cell culture model where SS-31 mitigates cisplatin-associated cell death and mitochondrial dysfunction. The identified hit candidate
-
Gene Therapy for Glomerular Disease J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-03-22 Moin A. Saleem
An abstract is unavailable.
-
Decision-Making Engagement Preferences among Older Adults with CKD J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-03-22 Kristina M. Gonzales, Susan Koch-Weser, Kristen Kennefick, Mary Lynch, Thalia Porteny, Hocine Tighiouart, John B. Wong, Tamara Isakova, Dena E. Rifkin, Elisa J. Gordon, Ana Rossi, Daniel E. Weiner, Keren Ladin
ney failure face preference-sensitive decisions regarding dialysis initiation. Despite recommendations, few older patients with kidney failure experience shared decision making. Clinician uncertainty about the degree to which older patients prefer to engage in decision making remains a key barrier. Methods This study follows a mixed-methods explanatory, longitudinal, sequential design at four diverse
-
Development and Validation of Staging Systems for AA Amyloidosis J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-03-21 Marco Basset, Stefan O. Schönland, Laura Obici, Janine Günther, Eloisa Riva, Tobias Dittrich, Paolo Milani, Virginia Valeria Ferretti, Ettore Pasquinucci, Andrea Foli, Christoph Kimmich, Martina Nanci, Claudia Bellofiore, Francesca Benigna, Jörg Beimler, Pietro Benvenuti, Francesca Fabris, Roberta Mussinelli, Mario Nuvolone, Catherine Klersy, Riccardo Albertini, Giampaolo Merlini, Ute Hegenbart, Giovanni
ts at high risk of progression to end-stage kidney failure.Prognostic stratification in AA amyloidosis can be easily made by staging systems, similarly to AL and transthyretin amyloidosis. Background The kidney is involved in almost 100% of cases of AA amyloidosis, a rare disease caused by persistent inflammation with long overall survival but frequent progression to kidney failure. Identification
-
WWP2 Regulates Renal Fibrosis and the Metabolic Reprogramming of Profibrotic Myofibroblasts J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-03-19 Huimei Chen, Ran You, Jing Guo, Wei Zhou, Gabriel Chew, Nithya Devapragash, Jui Zhi Loh, Loreto Gesualdo, Yanwei Li, Yuteng Jiang, Elisabeth Li Sa Tan, Shuang Chen, Paola Pontrelli, Francesco Pesce, Jacques Behmoaras, Aihua Zhang, Enrico Petretto
ugh the metabolic regulator peroxisome proliferator-activated receptor gamma coactivator 1-alpha. Background Renal fibrosis is a common pathologic end point in CKD that is challenging to reverse, and myofibroblasts are responsible for the accumulation of a fibrillar collagen–rich extracellular matrix. Recent studies have unveiled myofibroblasts' diversity in proliferative and fibrotic characteristics
-
The Challenge of Assessing Remission and Relapse in ANCA Kidney Disease J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-03-13 Brix, Silke R.
No abstract available
-
Secular Trends in Incidence of Treated Kidney Failure in the United States J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-03-13 Mallory L. Downie, Bethany J. Foster
An abstract is unavailable.
-
Watering Collecting Duct Cysts: Are Aquaporin2+ Progenitors the Answer? J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-03-13 Mauricio Ostrosky-Frid, Vishal Patel
An abstract is unavailable.
-
Posoleucel in Kidney Transplant Recipients with BK Viremia: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-03-12 Anil Chandraker, Anil Regmi, Reginald Gohh, Akhil Sharma, E. Steve Woodle, Mohammed J. Ansari, Vinay Nair, Ling-Xin Chen, Tarek Alhamad, Silas Norman, Diane Cibrik, Manpreet Singh, Arnold Alper, Divya Jain, Ziad Zaky, Stuart Knechtle, Asif Sharfuddin, Gaurav Gupta, Bonnie E. Lonze, Jo-Anne H. Young, Deborah Adey, Arman Faravardeh, Darshana M. Dadhania, Ana P. Rossi, Diana Florescu, Francesca Cardarelli
rsistence of posoleucel was confirmed by T-cell receptor variable β sequencing. Background Kidney transplant recipients with BK virus infection are at risk of developing BK virus–associated nephropathy, allograft rejection, and subsequent graft loss. There are no approved treatments for BK virus infection. Posoleucel is an off-the-shelf, allogeneic, multivirus-specific T-cell investigational therapy
-
Reduced Nephron Endowment in Six2-TGCtg Mice Is Due to Six3 Misexpression by Aberrant Enhancer–Promoter Interactions in the Transgene J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-03-06 Alison J. Perl, Han Liu, Matthew Hass, Nirpesh Adhikari, Praneet Chaturvedi, Yueh-Chiang Hu, Rulang Jiang, Yaping Liu, Raphael Kopan
long kidney function relies on the complement of nephrons generated during mammalian development from a mesenchymal nephron progenitor cell population. Low nephron endowment confers increased susceptibility to CKD. Reduced nephron numbers in the popular Six2TGC transgenic mouse line may be due to disruption of a regulatory gene at the integration site and/or ectopic expression of a gene(s) contained
-
Authors' Reply: Eculizumab Seems to be a Life Saver Even in Shiga Toxin-Related Hemolytic Uremic Syndrome J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-03-01 Garnier, Arnaud
No abstract available
-
Prioritizing Skills for Optimal Peritoneal Dialysis Care: A Focus Beyond Specialty J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-03-01 Sahutoglu, Tuncay
No abstract available
-
Assessment of Novel Therapeutics to Improve Access to Transplantation for Highly Sensitized Patients in a Shifting Clinical Landscape J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-03-01 Lan, James H.
No abstract available
-
Adenine Nucleotide Translocators Control Kidney Metabolism and Lipid Handling J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-03-01 Sugahara, Sho, Brooks, Craig R.
No abstract available
-
Heterogeneity of Distal Convoluted Tubule Cells J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-03-01 Murillo-de-Ozores, Adrián R., Chen, Lihe
No abstract available
-
-
Authors' Reply: Prioritizing Skills for Optimal Peritoneal Dialysis Care: A Focus Beyond Specialty J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-03-01 Ku, Elaine, McCulloch, Charles E., Copeland, Timothy P., Johansen, Kirsten L.
No abstract available
-
Eculizumab Seems to be a Life Saver Even in Shiga Toxin–Related Hemolytic–Uremic Syndrome J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-03-01 Pottokaran, Jaicy
No abstract available
-
-
Point-of-Care Clinical Trials in Nephrology J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-02-29 Sarah M. Leatherman, Areef Ishani
An abstract is unavailable.
-
Ondansetron and the Risk of Sudden Cardiac Death among Individuals Receiving Maintenance Hemodialysis J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2024-02-27 Sherin Ismail, Michele Jonsson Funk, Jennifer E. Flythe
igh incidence of sudden cardiac death and are susceptible to QT interval–prolonging medication–related cardiac complications. Ondansetron, an antiemetic with known QT-prolonging potential, is associated with fatal arrhythmias in the general population when administered intravenously. The cardiac safety of ondansetron in the hemodialysis population is unknown. Methods We conducted a new-user, active-comparator